Evaluation of circulating osteoprotegerin as a new biomarker in the metabolic syndrome: cardiovascular risk assessment, analytical factors and circulating sources
Tesis doctoral de Carmen Pérez De Ciriza Villacampa Osteoprotegerin (opg), an osteoclastogenesis inhibitor implicated in bone remodelling, has emerged as […]